✦ LIBER ✦

Bio and nanotechnological strategies for tumor-targeted gene therapy

✍ Scribed by Jeong-Hun Kang; Riki Toita; Yoshiki Katayama

Book ID: 113494818
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 371 KB
Volume: 28
Category: Article
ISSN: 0734-9750
DOI: 10.1016/j.biotechadv.2010.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for targeted gene therapy

✍ Jonathan D. Harris; Nick R. Lemoine 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 842 KB

Tumor-targeted gene therapy: strategies

Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexes

✍ Manfred Ogris; Greg Walker; Thomas Blessing; Ralf Kircheis; Markus Wolschek; Ern 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Strategies to optimize the use of target

Strategies to optimize the use of targeted agents for tumor therapy

✍ Jürgen C. Becker; Selma Ugurel; David Schrama 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 German ⚖ 244 KB

Nanotechnology for targeted drug and gen

Nanotechnology for targeted drug and gene delivery

✍ Mansoor M. Amiji 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 128 KB

How to overcome (and exploit) tumor hypo

How to overcome (and exploit) tumor hypoxia for targeted gene therapy

✍ Olga Greco; Brian Marples; Michael C. Joiner; Simon D. Scott 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 1 views

## Abstract Tumor hypoxia has long been recognized as a critical issue in oncology. Resistance of hypoxic areas has been shown to affect treatment outcome after radiation, chemotherapy, and surgery in a number of tumor sites. Two main strategies to overcome tumor hypoxia are to increase the deliver

Tumor cell targeted cytokine (TNF-α) gen

Tumor cell targeted cytokine (TNF-α) gene therapy for cancer

✍ Thomas Blankenstein; Zhihai Qin; Klaus Überta; H-Dieter Volk; Tibor Diamantstein 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 161 KB